Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 3
2005 1
2006 1
2008 3
2009 3
2010 6
2011 3
2012 4
2013 1
2014 6
2015 2
2016 5
2017 9
2018 5
2019 9
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean yasuo akiyama (9 results)?
Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Katano I, Ito M, Akiyama Y. Ashizawa T, et al. Among authors: akiyama y. Clin Cancer Res. 2017 Jan 1;23(1):149-158. doi: 10.1158/1078-0432.CCR-16-0122. Epub 2016 Jul 25. Clin Cancer Res. 2017. PMID: 27458246 Free article.
Impact of combination therapy with anti-PD-1 blockade and a STAT3 inhibitor on the tumor-infiltrating lymphocyte status.
Ashizawa T, Iizuka A, Maeda C, Tanaka E, Kondou R, Miyata H, Sugino T, Kawata T, Deguchi S, Mitsuya K, Hayashi N, Asai A, Ito M, Yamaguchi K, Akiyama Y. Ashizawa T, et al. Among authors: akiyama y. Immunol Lett. 2019 Dec;216:43-50. doi: 10.1016/j.imlet.2019.10.003. Epub 2019 Oct 3. Immunol Lett. 2019. PMID: 31586551 Free article.
Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors.
Ohshima K, Fujiya K, Nagashima T, Ohnami S, Hatakeyama K, Urakami K, Naruoka A, Watanabe Y, Moromizato S, Shimoda Y, Ohnami S, Serizawa M, Akiyama Y, Kusuhara M, Mochizuki T, Sugino T, Shiomi A, Tsubosa Y, Uesaka K, Terashima M, Yamaguchi K. Ohshima K, et al. Among authors: akiyama y. Cancer Sci. 2019 Dec;110(12):3821-3833. doi: 10.1111/cas.14202. Epub 2019 Oct 14. Cancer Sci. 2019. PMID: 31553483 Free PMC article.
Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.
Nonomura C, Otsuka M, Kondou R, Iizuka A, Miyata H, Ashizawa T, Sakura N, Yoshikawa S, Kiyohara Y, Ohshima K, Urakami K, Nagashima T, Ohnami S, Kusuhara M, Mitsuya K, Hayashi N, Nakasu Y, Mochizuki T, Yamaguchi K, Akiyama Y. Nonomura C, et al. Among authors: akiyama y. Immunol Lett. 2019 Apr;208:52-59. doi: 10.1016/j.imlet.2019.02.004. Epub 2019 Mar 14. Immunol Lett. 2019. PMID: 30880120 Free article.
Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy.
Hatakeyama K, Nagashima T, Ohshima K, Ohnami S, Ohnami S, Shimoda Y, Serizawa M, Maruyama K, Naruoka A, Akiyama Y, Urakami K, Kusuhara M, Mochizuki T, Yamaguchi K. Hatakeyama K, et al. Among authors: akiyama y. Cancer Sci. 2019 Aug;110(8):2620-2628. doi: 10.1111/cas.14087. Epub 2019 Jun 24. Cancer Sci. 2019. PMID: 31152682 Free PMC article.
A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
Iizuka A, Nonomura C, Ashizawa T, Kondou R, Ohshima K, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Akiyama Y. Iizuka A, et al. Among authors: akiyama y. Clin Cancer Res. 2019 May 1;25(9):2925-2934. doi: 10.1158/1078-0432.CCR-17-3123. Epub 2019 Feb 8. Clin Cancer Res. 2019. PMID: 30737243 Free article.
Tumor mutational burden analysis of 2,000 Japanese cancer genomes using whole exome and targeted gene panel sequencing.
Hatakeyama K, Nagashima T, Urakami K, Ohshima K, Serizawa M, Ohnami S, Shimoda Y, Ohnami S, Maruyama K, Naruoka A, Akiyama Y, Kusuhara M, Mochizuki T, Yamaguchi K. Hatakeyama K, et al. Among authors: akiyama y. Biomed Res. 2018;39(3):159-167. doi: 10.2220/biomedres.39.159. Biomed Res. 2018. PMID: 29899191 Free article.
Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse.
Ashizawa T, Iizuka A, Tanaka E, Kondou R, Miyata H, Maeda C, Sugino T, Yamaguchi K, Ando T, Ishikawa Y, Ito M, Akiyama Y. Ashizawa T, et al. Among authors: akiyama y. Biomed Res. 2019;40(6):243-250. doi: 10.2220/biomedres.40.243. Biomed Res. 2019. PMID: 31839668 Free article.
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, Tanabe T, Naruoka A, Kamada F, Serizawa M, Hatakeyama K, Matsumura K, Ohnami S, Maruyama K, Mochizuki T, Kusuhara M, Shiomi A, Ohde Y, Terashima M, Uesaka K, Onitsuka T, Nishimura S, Hirashima Y, Hayashi N, Kiyohara Y, Tsubosa Y, Katagiri H, Niwakawa M, Takahashi K, Kashiwagi H, Nakagawa M, Ishida Y, Sugino T, Takahashi M, Akiyama Y. Nagashima T, et al. Among authors: akiyama y. Cancer Sci. 2020 Feb;111(2):687-699. doi: 10.1111/cas.14290. Epub 2020 Jan 22. Cancer Sci. 2020. PMID: 31863614 Free PMC article.
Classification of tumor microenvironment immune types based on immune response-associated gene expression.
Kondou R, Iizuka A, Nonomura C, Miyata H, Ashizawa T, Nagashima T, Ohshima K, Urakami K, Kusuhara M, Yamaguchi K, Akiyama Y. Kondou R, et al. Among authors: akiyama y. Int J Oncol. 2019 Jan;54(1):219-228. doi: 10.3892/ijo.2018.4617. Epub 2018 Nov 2. Int J Oncol. 2019. PMID: 30387832
68 results
Jump to page
Feedback